Master of Industrial Drug Development - MIND

The Master of Industrial Drug Development programme consists of compulsory courses (30 ECTS credits), elective courses (10-18 ECTS credits) and a master thesis in an approved topic (12-20 ECTS credits).

It is up to the individual student to determine the sequence and pace of taking the courses. However, students are recommended to start with the "Discovery and Development of Medicines" course.

See prospective classes in the Danish description of the course.

Compulsory Courses:

• Discovery and Development of Medicines (5 ECTS): A comprehensive overview of drug development and an understanding of the dynamics of drug development and intercommunication across research disciplines.
• Drug Discovery (3 ECTS): Provides the student with an understanding of the elements involved in modern drug discovery including; target identification, validation and lead identification, and optimization.
• Pharmacology (2.5 ECTS): Pharmacology concepts applied in the drug development process. Basic concepts and drug classes are introduced. Emphasis is put on pharmacokinetics and experimental in vitro and in vivo tools.
• Non-clinical Safety and Toxicology (2.5 ECTS): The requirements and conclusions to be drawn from the results of non-clinical safety assessment conducted in vivo and in vitro.
• Drug Formulation and Delivery (4 ECTS): How optimal performance of drug formulation can be achieved by considering the physicochemical properties of the active pharmaceutical ingredient (API) and excipients.
• Chemical Process Development and Production of Active Pharmaceutical Ingredients (API) (3 ECTS): In depth knowledge of the different aspects of chemical process development from discovery through pilot plant size to optimized production scale synthesis and the preparation of a Drug Master File.
• Drug Regulatory Affairs in Drug Development (2.5 ECTS): How regulatory affairs professionals interact with the specialists involved in the process of drug development, the EU legislative framework, application procedures and strategic regulatory issues.
• QA, QC, GXP for Pharmaceutical Production (2.5 ECTS): Quality assurance and quality control of drug development and manufacture for worldwide distribution.
• Clinical Pharmacology and Biostatistics (5 ECTS): The clinical pharmacological considerations during drug development.
• Biopharmaceuticals - Pharmaceutical Development and Safety Assessment (3 ECTS): An introduction to the advances in the development of macromolecule use in biopharmaceuticals.

Elective courses: In collaboration with a supervisor assigned by the University, the student identifies relevant elective study units that support the student's personal study profile. Elective study units must be at postgraduate level, i.e. master or PhD-level, and offered to master's students by a university in Denmark or abroad.

Each course is completed with an examination. Registration for a course automatically entails registration for the subsequent examination.

The master project is a practice-oriented research project on an elective topic which allows the student to apply the acquired skills and knowledge to the host organization or company. The project is supervised by a university lecturer and a supervisor from the student's host organization or company.

The Faculty of Pharmaceutical Sciences, University of Copenhagen, offers the programme.

Master of Industrial Drug Development is a part-time programme of 2-6 years, equivalent to a 1-year full-time programme or 60 ECTS.

Applicants must meet the following criteria:

• A relevant higher education (bachelor degree or equivalent)
• A minimum of 2 years of relevant job experience
• Proficiency in English

A background in chemistry, biochemistry, pharmacy, engineering, health science or the like is relevant. Applicants with other backgrounds are welcome to apply.

The Study Board assesses whether the educational background and job experience of the applicant is relevant and sufficient. Applicants may be required to submit evidence of English proficiency.

It is possible to sign up for the individual courses instead of joining the full master programme.

Tuition fee

Entry fee
To enter the full master programme, students are required to pay a fee of DKK 15,000 upon registration.

Compulsory courses
Part-time students at PHARMA: in general DKK 15,780 for each 5 ECTS.

Freelance students: in general DKK 18,700 for each 5 ECTS.

Compulsory courses comprise 30 ECTS.

Master project
Master project fee: DKK 12,600

An additional fee varying from course to course will be charged for course materials and lunch.

Please note! Separate non-EU fees - see more on the homepage.

Read more about the rules for tuition fee in Denmark at www.studyindenmark.dk.

The programme is graded at level 7 in the Danish Qualification Framework for Lifelong Learning. The Qualification Framework contains levels 1-8 and defines the expected learning outcome of an education programme. Read more about Qualification Framework for Higher Education.

You can find information on practical issues related to your study visit in Denmark with Danish Agency for International Education, using either of the following links:

www.studyindenmark.dk

www.iu.dk